Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.
about
Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide.Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria.Insights from 100 Years of Research with Probiotic E. ColiExperimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs.Gut microbiota promote hematopoiesis to control bacterial infectionUnique activity spectrum of colicin FY: all 110 characterized Yersinia enterocolitica isolates were colicin FY susceptible.Disruption of Escherichia coli Nissle 1917 K5 capsule biosynthesis, through loss of distinct kfi genes, modulates interaction with intestinal epithelial cells and impact on cell health.The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.Live bacterial cells as orally delivered therapeutics.Probiotics: properties, examples, and specific applications.Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron.Role of deoxyribose catabolism in colonization of the murine intestine by pathogenic Escherichia coli strains.Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis.Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium.Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications.Unraveling the Differences between Gram-Positive and Gram-Negative Probiotics in Modulating Protective Immunity to Enteric Infections.Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917.The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in eNF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.Draft genome sequence and characterization of commensal Escherichia coli strain BG1 isolated from bovine gastro-intestinal tract.The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction.Modulation of Type 1 Diabetes Risk by the Intestinal Microbiome.Probiotics and E.coli infections in man.Prophylaxis of acute respiratory infections via improving the immune system in late preterm newborns with E. coli strain Nissle 1917: a controlled pilot trial.The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating InflammationSpecific Proliferative and Antibody Responses of Premature Infants to Intestinal Colonization with Nonpathogenic Probiotic E. coli Strain Nissle 1917
P2860
Q24535758-7E466CD0-AF4A-4180-81D4-C9BB60C45179Q24561803-F3350F07-9666-47D2-89B5-194424E64E5AQ24806569-EB5605AB-F4CA-4166-AABD-C609060E9268Q28079219-357DB15B-7058-4199-B8A3-3C471DF57755Q34083538-6C8AF2BB-1FA3-4696-BAFD-5530FFFABB68Q34089573-DE4B0EBE-057F-4D6B-A40C-31BAEAB97CC5Q35067652-17EC0572-0BB6-4DE9-BC7D-7E22C8DC1448Q35581546-F7403814-C443-42F5-88D1-121FE8C769A8Q35646959-55D641B1-F8DD-4D71-A6F7-280BE0227870Q36014389-F8D7BF84-E407-4E1A-A795-30D1AF541407Q36273383-C4A8ACAC-2433-43E9-963B-97A7912820A8Q36629073-6FA5627B-1D2B-4D5F-BF81-6A635DCC4DDAQ37118020-6735F51A-6B08-48CE-AC76-9BFEAC172878Q37145031-FEFC3C83-E726-4F80-94CE-19E10D459DBEQ37320010-128B9AA0-7869-4FF0-809F-7F23C5D26D8CQ37969596-6729946F-7810-4F36-A9F2-4F95974817C7Q38076755-1418CED0-6B24-459B-A384-37A7377195B6Q39233059-DB055A6B-2DA6-4BEC-8164-626E8E8DCFB7Q39498136-0366F7EC-4210-4442-A92A-9A00F6A98961Q39741559-AA942AE7-2117-4B30-9705-2469B6362AE6Q40017434-C83E53C4-B393-4834-B754-F7741F2970A1Q41761349-9D0347E8-0A2C-42BB-9D77-0068C8627565Q42374149-A88D46A4-3268-4852-A79F-D3B2AB6DA87DQ43097032-229DD75A-A745-4BA0-A034-37168E540E45Q46301789-036A06AC-E88D-4AE7-8F89-629B7DECEA06Q55055191-0AE8E187-0F0A-4F95-9979-B024A8461673Q55350606-C92936E3-5792-4399-AE89-2FB637AB3424Q57174271-1918564E-580A-4CAE-A63D-3EA354C79418Q58236993-66C1224E-7385-400A-AE57-581DB15D17B6
P2860
Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Effect of preventive administr ...... pathogens in newborn infants.
@en
Effect of preventive administr ...... pathogens in newborn infants.
@nl
type
label
Effect of preventive administr ...... pathogens in newborn infants.
@en
Effect of preventive administr ...... pathogens in newborn infants.
@nl
prefLabel
Effect of preventive administr ...... pathogens in newborn infants.
@en
Effect of preventive administr ...... pathogens in newborn infants.
@nl
P356
P1433
P1476
Effect of preventive administr ...... pathogens in newborn infants.
@en
P2093
R Lodinová-Zádniková
U Sonnenborn
P304
P356
10.1159/000244421
P407
P577
1997-01-01T00:00:00Z